CDC Division of Global HIV & TB country profile : India

The U.S. Centers for Disease Control and Prevention (CDC) established an office in India in 2001 to assist the National AIDS Control Organization (NACO) in addressing a concentrated HIV epidemic affecting key populations (KPs), such as female sex workers (FSW), men who have sex with men (MSM), transgender individuals, and people who inject drugs (PWID). CDC has worked with the Revised National TB Control Program (RNTCP) to address tuberculosis (TB), a major co-morbidity. Under the U.S. President\u2019s Emergency Plan for AIDS Relief (PEPFAR), CDC focuses on preventing new HIV infections, increasing access to care and treatment services for persons living with HIV (PLHIV) and TB, building a strong surveillance system, and strengthening the work of civil society organizations. To reach these goals, CDC assists the Government of India in achieving HIV epidemic control under the framework of the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 targets by increasing case detection, linkage, treatment, and retention in high priority districts with specialized programming for KP. The UNAIDS 90-90-90 targets are, by 2020: 90 percent of all PLHIV will know their HIV status; 90 percent of all people with diagnosed HIV infection will receive sustained antiretroviral therapy (ART); and 90 percent of all people receiving ART will have viral suppression. Further, CDC serves as leading partner in strengthening laboratory systems; and it supports public sector viral load (VL) scale-up and implementation of quality assurance measures for HIV testing including training India\u2019s laboratory workforce. CDC serves as a leading partner in national HIV surveillance efforts, which include using a single monitoring and evaluation system for effective, data- driven decision-making. CDC also works to enhance HIV-TB coordination to effectively diagnose and treat TB, multidrug-resistant (MDR) TB, and provide TB preventive treatment (TPT); and it supports RNTCP to end TB through improvement of diagnosis, treatment and prevention of TB and MDR TB through strengthening laboratory, surveillance and clinical capacityIndia.pdf2019665